4//SEC Filing
Quinn Grainne 4
Accession 0001585364-23-000031
CIK 0001585364other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:55 PM ET
Size
13.6 KB
Accession
0001585364-23-000031
Insider Transaction Report
Form 4
PERRIGO Co plcPRGO
Quinn Grainne
EVP, Chief Medical Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-03-07−2,250→ 4,498 total→ Ordinary Shares (2,250 underlying) - Award
Restricted Stock Units
2023-03-06+5,276→ 5,276 total→ Ordinary Shares (5,276 underlying) - Tax Payment
Ordinary Shares
2023-03-07$37.71/sh−1,170$44,121→ 14,063 total - Exercise/Conversion
Ordinary Shares
2023-03-07$37.71/sh+2,250$84,848→ 15,233 total
Footnotes (5)
- [F1]Vesting of service-based restricted stock units granted on 7 March 2022.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
- [F3]Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 7 March 2023.
- [F4]Grant of service-based restricted stock units granted on 6 March 2023.
- [F5]Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 March 2024.
Issuer
PERRIGO Co plc
CIK 0001585364
Entity typeother
Related Parties
1- filerCIK 0001679915
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:55 PM ET
- Size
- 13.6 KB